Literature DB >> 4185500

The treatment of severe myasthenia gravis with immunosuppressive agents.

H G Mertens, F Balzereit, M Leipert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4185500     DOI： 10.1159/000113809

Source DB:  PubMed          Journal:  Eur Neurol        ISSN： 0014-3022            Impact factor:   1.710


× No keyword cloud information.
  18 in total

Review 1.  Treatment of myasthenia gravis: focus on pyridostigmine.

Authors:  Lorenzo Maggi; Renato Mantegazza
Journal:  Clin Drug Investig       Date:  2011-10-01       Impact factor: 2.859

2.  Ocular myasthenia gravis: response to long-term immunosuppressive treatment.

Authors:  N Sommer; B Sigg; A Melms; M Weller; K Schepelmann; V Herzau; J Dichgans
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-02       Impact factor: 10.154

Review 3.  Immunopathogenesis and treatment of myasthenia gravis.

Authors:  A I Levinson; B Zweiman; R P Lisak
Journal:  J Clin Immunol       Date:  1987-05       Impact factor: 8.317

4.  Long term treatment of myasthenia gravis with azathioprine.

Authors:  V Fonseca; C W Havard
Journal:  Postgrad Med J       Date:  1990-02       Impact factor: 2.401

5.  [Thymectomy in the management of myasthenia].

Authors:  F Balzereit; V Bay; H Otto; P Rittmeyer; C Sobirey
Journal:  Z Neurol       Date:  1972

6.  Azathioprine as a single drug or in combination with steroids in the treatment of myasthenia gravis.

Authors:  R Mantegazza; C Antozzi; D Peluchetti; A Sghirlanzoni; F Cornelio
Journal:  J Neurol       Date:  1988-11       Impact factor: 4.849

Review 7.  Update on myasthenia gravis.

Authors:  B R Thanvi; T C N Lo
Journal:  Postgrad Med J       Date:  2004-12       Impact factor: 2.401

Review 8.  [Minimally invasive thymus surgery].

Authors:  J C Rückert; M Ismail; M Swierzy; C Braumann; H Badakhshi; P Rogalla; A Meisel; R I Rückert; J M Müller
Journal:  Chirurg       Date:  2008-01       Impact factor: 0.955

Review 9.  History of Myasthenia Gravis Revisited.

Authors:  Feza Deymeer
Journal:  Noro Psikiyatr Ars       Date:  2020-11-07       Impact factor: 1.339

10.  Plasma exchange and immunosuppressive drug treatment in myasthenia gravis: no evidence for synergy.

Authors:  C J Hawkey; J Newsom-Davis; A Vincent
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-06       Impact factor: 10.154
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.